Search

Your search keyword '"Sherwood, Matthew W."' showing total 396 results

Search Constraints

Start Over You searched for: Author "Sherwood, Matthew W." Remove constraint Author: "Sherwood, Matthew W."
396 results on '"Sherwood, Matthew W."'

Search Results

101. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

103. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

105. Apixaban following acute coronary syndromes in patients with prior stroke : Insights from the APPRAISE-2 trial

106. Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry

107. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention:The ROCKET AF Trial

109. Impact of Regional Systems of Care on Disparities in Care Among Female and Black Patients Presenting With ST‐Segment–Elevation Myocardial Infarction

110. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States

112. PREDICTORS OF MORTALITY AFTER TAVR IN A “REAL WORLD” SETTING

113. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

114. Regional Systems of Care Demonstration Project

116. Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin

118. Abstract 17432: Specific Care Process Implementation Associated With Improved Reperfusion Times Across Multiple STEMI Networks: Insights From The AHA Mission: Lifeline STEMI Accelerator Program

124. Early Dynamic Risk Stratification with Baseline Troponin Levels and 90-minute ST Segment Resolution to Predict 30 Day Cardiovascular Mortality in STEMI: Analysis from CLARITY TIMI-28

126. Abstract 18816: Relationship of Aortic Valve Surgery and Survival in Patients with Moderate or Severe Aortic Stenosis and Left Ventricular Dysfunction

127. Abstract 141: Outcomes Associated with Temporarily Interrupting Anticoagulation in Outpatients with Atrial Fibrillation: Results from ORBIT-AF

129. Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

130. THE USE OF DUAL ANTIPLATELET THERAPY AND PATIENT OUTCOMES IN THOSE UNDERGOING PCI IN THE ROCKET AF TRIAL

134. Factors Associated With Major Bleeding Events

140. Blood Transfusion After Percutaneous Coronary Intervention and Risk of Subsequent Adverse Outcomes.

141. The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States.

143. Abstract 12839: A Standardized and Regionalized System of Care Network for Cardiogenic Shock: Insights From the Inova-Shock Registry

145. Blood Transfusion After Percutaneous Coronary Intervention and Risk of Subsequent Adverse Outcomes A Systematic Review and Meta-Analysis

146. Factors Associated With Major Bleeding Events Insights From the ROCKET AF Trial (Rivaroxaban Once-daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)

147. Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin ROCKET AF Trial

149. Transcatheter Aortic Valve Replacement in Low-Population Density Areas: Assessing Healthcare Access for Older Adults With Severe Aortic Stenosis.

150. Abstract 14942: The Influence of Heart Failure on Clinical and Economic Outcomes for Older Patients Presenting With Acute Myocardial Infarction

Catalog

Books, media, physical & digital resources